BIOMAT Database Logo BIOMAT Database Logo

Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics. 1977

E Moncada Lorenzo, and R V Garcia, and J J Barberia Layana, and J A Morant Ciscard, and A Calleja Canelas

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral

Related Publications

E Moncada Lorenzo, and R V Garcia, and J J Barberia Layana, and J A Morant Ciscard, and A Calleja Canelas
Clinical experience with glibenclamide in 300 diabetics.
December 1970, Postgraduate medical journal,
E Moncada Lorenzo, and R V Garcia, and J J Barberia Layana, and J A Morant Ciscard, and A Calleja Canelas
Comparison of short-term effects of glibenclamide and chlorpropamide in newly diagnosed diabetics.
December 1970, Postgraduate medical journal,
E Moncada Lorenzo, and R V Garcia, and J J Barberia Layana, and J A Morant Ciscard, and A Calleja Canelas
Effects of sulfonylureas (tolbutamide, glipentide and glibenclamide) on in vitro glycerol metabolism in adipose tissue from rats.
February 1975, Life sciences,
E Moncada Lorenzo, and R V Garcia, and J J Barberia Layana, and J A Morant Ciscard, and A Calleja Canelas
Hypertensive crisis: comparison between diabetics and non-diabetics.
January 2012, International journal of cardiology,
E Moncada Lorenzo, and R V Garcia, and J J Barberia Layana, and J A Morant Ciscard, and A Calleja Canelas
Bacterial pneumonia: comparison between diabetics and non-diabetics.
January 2001, Acta diabetologica,
E Moncada Lorenzo, and R V Garcia, and J J Barberia Layana, and J A Morant Ciscard, and A Calleja Canelas
A comparison of glibenclamide and chlorpropamide in the treatment of non-obese maturity onset diabetics.
December 1970, Postgraduate medical journal,
E Moncada Lorenzo, and R V Garcia, and J J Barberia Layana, and J A Morant Ciscard, and A Calleja Canelas
Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics.
January 1984, European journal of clinical pharmacology,
E Moncada Lorenzo, and R V Garcia, and J J Barberia Layana, and J A Morant Ciscard, and A Calleja Canelas
[Glibenclamide-phenformin in diabetics with failures after sulfonylureas].
December 1971, La Prensa medica mexicana,
E Moncada Lorenzo, and R V Garcia, and J J Barberia Layana, and J A Morant Ciscard, and A Calleja Canelas
Glibenclamide, acute/long-term response in M.O. diabetics.
June 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
E Moncada Lorenzo, and R V Garcia, and J J Barberia Layana, and J A Morant Ciscard, and A Calleja Canelas
[Our observations on diabetics treated with glibenclamide].
January 1976, Orvosi hetilap,
Copied contents to your clipboard!